中文名：RK-33
英文名：RK-33
英文別名：2H-?Diimidazo[4,?5-?d:4',?5'-?f]?[1,?3]?diazepin-?2-?one, 3,?7-?dihydro-?3,?7-?bis[(4-?methoxyphenyl)?methyl]?-
純度：10mM in DMSO
貨號(hào)：R408134
包裝：1ml
Cas號(hào)：1070773-09-9
存儲(chǔ)溫度：-80℃儲(chǔ)存
產(chǎn)品介紹：
Information
RK-33 RK-33 is a first-in-class small molecule inhibitor of DDX3 (a RNA helicase) and causes G1 cell cycle arrest, induces apoptosis, and promotes radiation sensitization in DDX3-overexpressing cells.
In?vitro
RK-33 binds specifically to DDX3, but not to the closely related proteins DDX5 and DDX17. RK-33 inhibits cancer growth and radiosensitizes lung cancer cells in a DDX3-dependent manner. RK-33 has no effect on either mitochondrial respiration or ATP generation. RK-33 curbs proliferation and induces apoptosis in a DDX3-dependent fashion. Wnt signaling is mediated by DDX3 and inhibited by RK-33. RK-33 impairs radiation-induced DNA damage repair by inhibiting NHEJ activity.
In?vivo
RK-33 in combination with radiation induces tumor regression in multiple mouse models of lung cancer. RK-33, at the dose used, is non-toxic in SCID mice. RK-33-treated mice do not exhibit any discernable morphological changes.
Cell?Data
cell?lines：
Concentrations：7.5 μM
Incubation?Time：12 h
Powder?Purity:≥99%
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對(duì)應(yīng)頁面：https://www.aladdin-e.com/zh_cn/R408134.html
關(guān)鍵字： 2H-?Diimidazo[4,?5-?d:4',?5'-?f]?[1,?3]?diazepin-?2-?one, 3,?7-?dihydro-?3,?7-?bis[(4-?methoxyphenyl)?methyl]?-
上海阿拉丁生化科技股份有限公司是A股上市公司（（股票代碼：688179），專注于科研試劑的研發(fā)、生產(chǎn)和銷售，已陸續(xù)建立多個(gè)工廠和研發(fā)中心。作為領(lǐng)軍企業(yè)，阿拉丁始終堅(jiān)持質(zhì)量第一，連續(xù)13年被評(píng)為“最受歡迎試劑品牌”。
阿拉丁目前常備庫存試劑產(chǎn)品品種超過7萬種，SKU總數(shù)超過46萬，產(chǎn)品線涵蓋了化學(xué)試劑、生化試劑、藥靶配體、蛋白質(zhì)和抗體等多個(gè)領(lǐng)域，是國內(nèi)少數(shù)化學(xué)試劑到生物試劑全面發(fā)展的國產(chǎn)試劑品牌，產(chǎn)品同步發(fā)布在我們國內(nèi)外電商平臺(tái)。